These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1657632)

  • 61. Platelet activating factor: regulation by mast cells and aspirin.
    Denburg JA; Williams DB; Kinlough-Rathbone RL; Cazenave JP; Bienenstock J
    Agents Actions; 1984 Feb; 14(2):300-5. PubMed ID: 6711391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves.
    Van de Weerdt ML; Husson C; Lekeux P
    Zentralbl Veterinarmed A; 1999 Mar; 46(2):103-13. PubMed ID: 10216447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A simple and precise method for the routine determination of platelet-activating factor in blood and urine.
    Demopoulos CA; Andrikopoulos NK; Antonopoulou S
    Lipids; 1994 Apr; 29(4):305-9. PubMed ID: 8177023
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oral nafazatrom in man: effect on inhaled antigen challenge.
    Fuller RW; Maltby N; Richmond R; Dollery CT; Taylor GW; Ritter W; Philipp E
    Br J Clin Pharmacol; 1987 Jun; 23(6):677-81. PubMed ID: 3038156
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro.
    Feldman C; Anderson R; Theron AJ; Steel HC; van Rensburg CE; Cole PJ; Wilson R
    Eur Respir J; 2001 Jul; 18(1):122-9. PubMed ID: 11510782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro.
    Feldman C; Anderson R; Theron AJ; Ramafi G; Cole PJ; Wilson R
    Inflammation; 1997 Dec; 21(6):655-65. PubMed ID: 9429912
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.
    Anderson R; Theron AJ; Feldman C
    Inflammation; 1996 Dec; 20(6):693-705. PubMed ID: 8979156
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
    Kahhak L; Roche A; Dubray C; Arnoux C; Benveniste J
    Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro.
    Anderson R; Feldman C; Theron AJ; Ramafi G; Cole PJ; Wilson R
    Br J Pharmacol; 1996 Apr; 117(7):1387-94. PubMed ID: 8730730
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
    Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
    Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polymorphonuclear leukocyte-generated oxygen metabolites decrease beat frequency of human respiratory cilia.
    Kantar A; Oggiano N; Giorgi PL; Braga PC; Fiorini R
    Lung; 1994; 172(4):215-22. PubMed ID: 8028389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultrastructure and mucociliary transport of bronchial respiratory epithelium in intubated patients.
    Konrad F; Schiener R; Marx T; Georgieff M
    Intensive Care Med; 1995 Jun; 21(6):482-9. PubMed ID: 7560491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.
    Lai CK; Jenkins JR; Polosa R; Holgate ST
    J Appl Physiol (1985); 1990 Mar; 68(3):919-26. PubMed ID: 2187854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness.
    Wardlaw AJ; Chung KF; Moqbel R; MacDonald AJ; Hartnell A; McCusker M; Collins JV; Barnes PJ; Kay AB
    Am Rev Respir Dis; 1990 Feb; 141(2):386-92. PubMed ID: 2405759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man.
    Nieminen MM; Moilanen EK; Nyholm J-E ; Koskinen MO; Karvonen JI; Metsä-Ketelä TJ; Vapaatalo H
    Eur Respir J; 1991 May; 4(5):551-60. PubMed ID: 1657632
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man.
    Nieminen MM; Moilanen EK; Koskinen MO; Karvonen JI; Tuomisto L; Metsä-Ketelä TJ; Vapaatalo H
    Br J Clin Pharmacol; 1992 Jun; 33(6):645-52. PubMed ID: 1327049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects.
    Bellofiore S; Ciancio N; Pennisi A; Coco G; Passanisi G; Ricciardolo FL; Novo S; Di Maria GU
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):288-92. PubMed ID: 8000412
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.